Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ADAC riding 2 profitable trends! Cryptocurrency and Defense spending are up! “The current emphasis in Washington being placed on rebuilding and investing in our military has resulted in a strong upswing of both contracts under development as well as contracts we are currently bidding on. We are really expecting this to be a record year for our revenues,” stated Harold Tanner, President of Adama Technologies. Mr. Tanner also serves as head of operations for the defense contracting company."
Thats the beauty of having stock in a holding company/ venture capital firm like $ADAC. The diversification can only mean the bets are stronger all around. Just as they are making headway in the crypto space, good news comes in from the defense sector. Nice to not have all the eggs in one basket.
Up Green 34% $ADAC breakout! To the moon baby!
AWESOME! GREAT News $LXGTF!
$LXGTF HeartSentry is the only option available to have day to day endothelial function monitoring without the need for a clinical setting. And that means life or death in the case of the 50% of heart attack victims who have no advance warning before the attack. HeartSentry will change all that.
Great to be above that 5 resistance level, if we can keep the pressure on ask we should be able to leg up to 7 quick.
Exactly! $ADAC is a winner by a mile
$LXGTF churning this morning in the low 40s
Wow! $400k revs 1stQ, and $2mil expected to be received total for $ADAC's defense contracts this year! This is huge good news.
GREAT NEWS! $ADAC "Adama Technologies Corp Announces Revenue Numbers, Bids and Projections for Defense Contracts"
http://www.otcmarkets.com/stock/ADAC/news
Las Vegas, Nevada (FSCwire) - Adama Technologies Corp. (OTCPINK: ADAC) announced today that their revenue projections for 2018 include over $400,000 of completed government defense contracts that are expected to be paid out in the first quarter of 2018. For the full year, based on current contracts already in production, Adama expects to receive more than $2 Million in 2018 revenue from defense contracts alone.
“The current emphasis in Washington being placed on rebuilding and investing in our military has resulted in a strong upswing of both contracts under development as well as contracts we are currently bidding on. We are really expecting this to be a record year for our revenues,” stated Harold Tanner, President of Adama Technologies. Mr. Tanner also serves as head of operations for the defense contracting company.
The Company also stated that they have already bid on an addition $1.2 million in new defense contracts this month. Mr. Tanner continued, “There are numerous contracts that are currently being evaluated and bid on and we are really excited about the future of the business within this space. In evaluating the opportunities that exist within the defense industries along with the other business verticals Adama is currently developing and invested in, this looks like it is going to be a very exciting year on all fronts.”
About Adama Technologies Military Defense Operations
Adama Technologies completed the acquisition of Alpine Industries in November of 2016. Alpine Industries is a precision machining and aerospace manufacturing company. Since its inception in 1974, Alpine has manufactured several hundred aerospace landing gear components and other spare parts. Alpine continues to work as a US government contractor and currently holds over 15 US Military contracts with the majority of them with the US Air Force. Presently, Alpine manufactures such items as M1 Mine Clearing Blades, hypo-chlorination units, tow bridles, 60 ton jacks for the C5A, AIM-9 missile body trainers, numerous bolts and screws, drag links for the F-16 fighter planes, and many other landing gear parts. In addition to the US military, Alpine also manufactures parts for several private companies including parts for drilling components used in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, and drilling carts.
Contact Information:
Address:
1000 N. Green Valley
Suite 380
Henderson, NV 89074
Phone: (866) 859-8697
Website: www.AdamaTechnologies.com
$ADAC good day to be in Crypto
Lets see what tomorrows trading brings for LXGTF.
That would be a cherry on top ending for this phase of the $LXGTF development.
Yeah once you click on it, Google remembers it and starts popping up all over LOL. Way to get the word out about $LXGTF Google! LOL
2 great links to start your $LXGTF research with: LXGTF website: https://lexingtonbiosciences.com/
LXGTF HeartSentry video: https://vimeo.com/183611304
Once FDA clearance is obtained, the plan it to market it for clinical use, but also as a personal retail portable device that can be operated by a non medically trained consumer. Very big market potential.
LXGTF HeartSentry is not to market yet. Its currently awaiting IRB approval to begin clinical tests , after that FDA clearance. Full commercialization is expected before we are done with 2018.
But the real sweet endgame for investors would be for $LXGTF to be acquired by a big Biomed once FDA clearance is a reality.
No problem AntMiner, let me know how it strikes you. Should be a multibagger from here once its done with FDA Clearance.
And this is a longer slide presentation: https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf
This is the key concept to wrap your mind around if you want to understand what $LXGTF is all about: Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
Another good link/ Executive Summary: https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-BioSciences-Overview-v6.pdf
Give the DD at least 15 minutes and let me know what you think.
Good place for learning about $LXGTF here: https://lexingtonbiosciences.com/
and here: https://vimeo.com/183611304
LOL, I'm a bit of true believer here. This is a LONG for me definitely. The science is indisputable, the market has no real competition and we are talking about the top disease killer in the modern world which currently has no advance warning in 50% of cases. $LXGTF HeartSentry will disrupt all that for the better. Take a moment with the DD and you'll see what I mean.
Basically $LXGTF HeartSentry is going to save alot of lives.
This is not your average penny, even if saying so is cliche. Years of peer-reviewed research here out a Noble Prize winning lab pointing to Endothelial Function monitoring as being the best way to warn of upcoming heart attack and stoke. Those two diseases are responsible for over 30% of all deaths in the modern world, but current diagnostic standards like BP monitors give no advance warning in 50% of all heart attack sufferers. $LXGTF HeartSentry measures endothelial function in a more simple, portable, accurate, and cost effective manner than any competing techs by miles.
$LXGTF is in between big announcements. They are awaiting IRB approval to begin clinical trials. Should be within months then we should see this break out of this range.
I would like to see more articles posted on the $LXGTF website. Maybe a blog from the CEO to keep investors in the loop between major PRs.
So yeah, Johnathan Maltz and the $LXGTF executive team: quite the deep bench.
Well he comes out of Berkeley labs, where they have won 13 Noble Prizes over the year and he spearheaded ten plus years of peer reviewed research into endothelial function and how it affects cardiovascular heath.
The guys a genius and the prinicpal inventor of the HeartSentry device. $LXGTF is very fortunate to have him on the team. He is a key ingredient in the secret sauce.
We need a big fat PR that $LXGTF has begun the clinical tests with human subjects with a projected time frame for finishing. That should rattle the cage.
Indubitably.
Chart shows popping up past .43 and building support there would make a big difference away from this lateral trend: https://www.barchart.com/stocks/quotes/LXGTF/technical-chart?plot=CANDLE&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=HLMA(10,8);RSI(14,100)&sym=LXGTF&grid=1&height=500&studyheight=100
$LXGTF needs to break this rangebound pattern.
And that contributes a lion's share to the deaths caused every year by heart attack and stroke. In fact its fully ONE THIRD of all deaths that will happen this year. Its staggering to think that this simple HeartSentry device could actually turn the tide on those numbers for the good of humanity. Lots at stake for $LXGTF
$LXGTF closed at .423 up a half percent green. More range bound MOMO for today.
It has to go this route. Current diagnostic standbys are failing the 50% of heart attack sufferers who had no advance warning before the event. $LXGTF can raise the warning flag in time for prevention.
$LXGTF will make it so there will come a day when you come back from the Dr. office your wife will ask you not "How's your blood pressure?" but "Whats your endothelial reading?" it will become the first diagnostic step in evaluating patient health.